Sign in
CompletedNo phase

Renal Cell Arrest and Damage Biomarkers in Progression and Outcome of Septic AKI

Key facts

Who runs it
Alexandria University
Where
Egypt1 site in 1 countryChoose a country to see its sites
Trial code
Status
Completed
People taking part
80 people enrolled
Started
1 Oct 2023
Ended
1 Jun 2024
Type of study
Interventional
Treatments tested
  • renal cell arrest and damage biomarkers assessment
Record updated
18 June 2024

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 10 criteriaShow less

Who can take part

  • AKI stage 1 or 2 according to KDIGO definition
  • Sepsis is defined based on the third international consensus definitions for sepsis and septic shock (Sepsis-3) as life threatening organ dysfunction caused by a dysregulated host response to infection. At least two of systemic inflammatory response syndrome (SIRS) criteria should be present

Who cannot take part

  • Previous renal replacement therapy
  • Renal transplant recipients
  • Hepatorenal syndrome
  • Patients for whom survival to 30 days is unlikely due to end stage disease (end stage liver or heart disease or untreatable malignancy)
  • Patients with pre-existing chronic kidney disease (eGFR<60 ml/min/1.73m2)
  • Age less than 18 years
  • Acute kidney injury caused by permanent postrenal obstruction
  • Pregnancy

Where is this trial?

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

The aim of the current study is to assess the predictive value of renal cell arrest biomarkers (urinary TIMP2 and IGFBP7), renal damage biomarkers (urinary KIM-1) and microscopic examination of urinary sediment in progression and outcome of sepsis associated AKI.

The group in the trial

  • septic AKI patientsTreatment being tested

    80 patients with sepsis associated AKI stage 1 or 2 according to KDIGO definition

    Treatment: renal cell arrest and damage biomarkers assessment

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Role of Renal Cell Arrest and Damage Biomarkers in Progression and Outcome of Sepsis Associated AKI
Publications
Record updated
18 June 2024